2021 Georgia Code
Title 31 - Health
Chapter 52 - Terminally Ill Patient's Right to Try Investigational Drugs, Biological Products, and Devices
§ 31-52-10. Statutory Construction

Universal Citation: GA Code § 31-52-10 (2021)
  1. This chapter shall not be construed to create a private cause of action against a manufacturer of an investigational drug, biological product, or device or against any other person or entity involved in the care of an eligible patient using an investigational drug, biological product, or device for any harm done to the eligible patient resulting from the investigational drug, biological product, or device if the manufacturer or other person or entity is complying in good faith with the terms of this chapter and has exercised reasonable care.
  2. Any person or entity providing treatment to an eligible patient using an investigational drug, biological product, or device shall not be liable for injury or death to such eligible patient as a result of the investigational drug, biological product, or device under Code Section 51-1-27 or 51-4-1, et seq., unless it is shown that the person or entity failed to obtain written informed consent in compliance with Code Section 31-52-5.
  3. This chapter shall not be construed to affect any required health care coverage under Title 33 for patients in clinical trials.

(a.1)This chapter shall not be construed to create a private cause of action against a physician who refuses to recommend an investigational drug, biological product, or device for any otherwise eligible patient.

(Code 1981, §31-52-10, enacted by Ga. L. 2016, p. 345, § 1/HB 34.)

Disclaimer: These codes may not be the most recent version. Georgia may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.